Table A4.

Logistic model on the impact of CKD on incident AF adjusted by age, sex, comorbidities and laboratory measurements (Model A), by sex (Model B) and by sex, comorbidities, and laboratory measurements (Model C) n = 2386, AF = 112.

	OR (95% CI)	p-Value
Model A
CKD Stage (eGFR 30–59 mL/min vs. eGFR > 60 mL/min)	0.808 (0.496–1.318)	0.3935
CKD Stage (eGFR < 30 mL/min vs. eGFR > 60 mL/min)	1.210 (0.613–2.389)	0.5832
Age (years)	1.052 (1.034–1.069)	<0.0001
Sex (M vs. F)	1.504 (0.970–2.334)	0.0683
Ischemic Heart Disease (Yes vs. No)	0.738 (0.386–1.412)	0.3593
Congestive Heart Failure (Yes vs. No)	1.108 (0.475–2.585)	0.8127
Diabetes (Yes vs. No)	0.969 (0.595–1.577)	0.8984
Hemoglobin (g/dL)	0.980 (0.882–1.088)	0.7021
Potassium (mmol/L)	1.120 (0.798–1.571)	0.5124
Model B
CKD Stage (eGFR 30–59 mL/min vs. eGFR > 60 mL/min)	1.620 (1.098–2.391)	0.0150
CKD Stage (eGFR < 30 mL/min vs. eGFR > 60 mL/min)	2.613 (1.548–4.410)	0.0003
Sex (M vs. F)	0.823 (0.823–1.712)	0.3582
Model C
CKD Stage (eGFR 30–59 mL/min vs. eGFR > 60 mL/min)	1.509 (0.959–1.318)	0.0754
CKD Stage (eGFR < 30 mL/min vs. eGFR > 60 mL/min)	2.227 (1.159–4.280)	0.0163
Sex (M vs. F)	1.317 (0.853–2.035)	0.2143
Ischemic Heart Disease (Yes vs. No)	0.921(0.480–1.767)	0.8045
Congestive Heart Failure (Yes vs. No)	1.267 (0.546- 2.940)	0.5823
Diabetes (Yes vs. No)	1.096 (0.673–1.783)	0.7125
Hemoglobin (g/dL)	0.957 (0.863–1.062)	0.4105
Potassium (mmol/L)	1.062 (0.754–1.496)	0.7323

Abbreviations: AF, atrial fibrillation; CKD, chronic kidney disease; n, number; eGFR, estimated glomerular filtration rate; OR, odds ratio.